Aviance Capital Partners LLC cut its position in CVS Health Corp (NYSE:CVS) by 21.4% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,696 shares of the pharmacy operator’s stock after selling 3,990 shares during the quarter. Aviance Capital Partners LLC’s holdings in CVS Health were worth $793,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in CVS. Oregon Public Employees Retirement Fund raised its holdings in CVS Health by 6,858.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 25,089,377 shares of the pharmacy operator’s stock worth $383,000 after purchasing an additional 24,728,818 shares in the last quarter. BlackRock Inc. raised its holdings in CVS Health by 22.0% in the fourth quarter. BlackRock Inc. now owns 92,954,958 shares of the pharmacy operator’s stock worth $6,090,409,000 after purchasing an additional 16,757,941 shares in the last quarter. Norges Bank bought a new position in CVS Health in the fourth quarter worth about $840,254,000. FMR LLC raised its holdings in CVS Health by 30.6% in the fourth quarter. FMR LLC now owns 39,263,265 shares of the pharmacy operator’s stock worth $2,572,528,000 after purchasing an additional 9,194,005 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in CVS Health by 36.2% in the fourth quarter. Geode Capital Management LLC now owns 16,462,292 shares of the pharmacy operator’s stock worth $1,076,697,000 after purchasing an additional 4,376,604 shares in the last quarter. Institutional investors and hedge funds own 77.28% of the company’s stock.
CVS Health stock traded up $0.37 during mid-day trading on Friday, hitting $55.57. The company had a trading volume of 4,264,184 shares, compared to its average volume of 7,280,391. The company has a debt-to-equity ratio of 1.45, a current ratio of 0.95 and a quick ratio of 0.64. CVS Health Corp has a 12-month low of $51.72 and a 12-month high of $82.15. The firm’s fifty day moving average is $53.81. The stock has a market cap of $72.19 billion, a P/E ratio of 7.85, a price-to-earnings-growth ratio of 1.12 and a beta of 0.88.
Several equities analysts have recently issued reports on the stock. ValuEngine downgraded shares of CVS Health from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 2nd. Mizuho set a $71.00 price objective on shares of CVS Health and gave the company a “buy” rating in a report on Wednesday, June 5th. Standpoint Research upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Wednesday, June 5th. BMO Capital Markets set a $63.00 price objective on shares of CVS Health and gave the company a “hold” rating in a report on Friday, May 3rd. Finally, Barclays set a $73.00 price target on shares of CVS Health and gave the stock a “buy” rating in a report on Thursday, April 11th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $76.48.
CVS Health Company Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
See Also: Resistance Level
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.